About
Leadership
Board of Directors
Scientific Advisors
Careers
Contact Us
Technology
Publications
Collaborations
Pipeline & Clinical Trials
FCX-007 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa
FCX-013 Gene Therapy for Localized Scleroderma
Gene Therapy Research Program for Arthritis and Related Conditions
Clinical Trials
Investors
Stock Information
News, Events & Presentations
SEC Filings
Corporate Governance
Analyst Coverage
Investor FAQs
Investor Contacts
Patients & Families
Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Localized Scleroderma
Arthritis and Related Conditions
News, Events &
Presentations
Contact
Toggle navigation
SEC Filings
Investors
|
SEC Filings
Back
Form PRE 14A
FIBROCELL SCIENCE, INC. filed this
Form PRE 14A
on 03/19/2018
Document Outline
Entire Document (2731.8 KB)
Subdocument 1 - PRE 14A - PRE 14A
Page 1 - N/A
Page 2 - N/A
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - N/A
Page 16 - N/A
Page 17 - N/A
Page 18 - N/A
Page 19 - N/A
Page 20 - N/A
Page 21 - N/A
Page 22 - N/A
Page 23 - N/A
Page 24 - N/A
Page 25 - N/A
Page 26 - N/A
Page 27 - N/A
Page 28 - N/A
Page 29 - N/A
Page 30 - N/A
Page 31 - N/A
Page 32 - N/A
Page 33 - N/A
Page 34 - N/A
Page 35 - N/A
Page 36 - N/A
Page 37 - N/A
Page 38 - N/A
Page 39 - N/A
Page 40 - N/A
Page 41 - N/A
Page 42 - N/A
Page 43 - N/A
Page 44 - N/A
Page 45 - N/A
Page 46 - N/A
Page 47 - N/A
Page 48 - N/A
Page 49 - N/A
Page 50 - N/A
Page 51 - N/A
Page 52 - N/A
Page 53 - N/A
Page 54 - N/A
Page 55 - N/A
Page 56 - N/A